Boston Scientific Wins $19.5M In Stent Patent Case

Law360, Los Angeles (May 11, 2011, 7:35 PM EDT) -- A federal jury in Delaware on Wednesday awarded $19.5 million to Boston Scientific Corp. in a patent infringement suit against Johnson & Johnson unit Cordis Corp. over one of Cordis’ Cypher heart stents.

"We are pleased to see the jury recognize the value of our intellectual property," Boston Scientific Executive Vice President Hank Kucheman said in a statement Wednesday. "This is an important outcome in protecting our market position in small-vessel, drug-eluting stents against infringing products."

The verdict marks the tail end of nearly a decade...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.